Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Deutsche Bank says that with a number of upcoming catalysts, it sees an attractive risk/reward...

  • Monday, June 18, 2012, 3:23 PM ET
    Deutsche Bank says that with a number of upcoming catalysts, it sees an attractive risk/reward profile in Teva (TEVA +0.2%) at current levels. The firm targets a $10 potential upside on the shares, with $3 potential downside. The firm reiterates its Buy rating with a $48 price target.
Track new comments on this story

This news story has 1 comment:

  •  
    Teva should profit with wider usage of generics with new health care provisions.
    30 Jun 2012, 08:59 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »